Register
Hello, !
Edit Profile | Logout

Trade: Buy PMTI

Rating: not yet rated    Vote: Terrible (-3)Worse (-2)Bad (-1)So-so (0)Good (+1)Better (+2)Best (+3)
User name*: '    Password*:
or register if you are a new user
User name*:
First name*:
Last name*:
Password*:
E-mail*:
Retype e-mail*:
Opt-In: Yes, send me email from InvestorPlace Blogs regarding blog post notifications and voting/commenting bulletins, along with The Investor Post weekly e-letter. Please un-check this box if you would prefer not to receive email from us.
Privacy Policy
InvestorPlace Blogs is powered by Marketocracy. Marketocracy has authorized Investor Place Blogs as an official registrar for voting through Marketocracy's Investment Research Rating service. Registered members of InvestorPlace Blogs are linked with a Marketocracy account to establish voting power based on their performance of trading and posting on stocks.

Yesterday I bought Palomar Medical, a leading producer of aesthetic laser products. Along with steady growth and well managed financials (EBITDA/EV = 13%, normalized EBIT/EV = 9%, EBIT/TC > 100%) they have huge upside potential because of their partnership with consumer giants Gillette as well as Johnson & Johnson to make lasers that can be used at home. This feeds into secular trend due to the demographics of aging population. The stock was recently hammered due to a perceived miss in the royalty revenues PMTI receives from other competitors. In my opinion, this "miss" is not significant; the royalties are simply an indication of technology leadership. In the long term I expect PMTI as well as ELOS to dominate this niche and the sector to consolidate.

Post a comment

You are logged in as . Log out


Comment Preview
Preview your comment here

You must be logged in to comment. Click here to register.